Emerald Development Managers is a New York-based venture capital firm established in 1994, specializing in early-stage growth equity investments. The firm primarily focuses on sectors such as health technology, biopharma, cybersecurity, enterprise software, industrial, and cleantech. Leveraging decades-long relationships with academic institutions, operating managers, angel investors, and other venture capitalists, Emerald Development Managers sources its investment opportunities effectively. The firm distinguishes itself by offering not only capital but also valuable mentorship, combining experience and critical thinking with hands-on involvement to support the growth of the companies it invests in. This approach, often referred to as "mentor capital," emphasizes both financial and strategic guidance to foster sustainable development in its portfolio.
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Uviquity
Venture Round in 2024
Uviquity is a semiconductor manufacturer based in Raleigh, North Carolina, focused on enhancing safety for its clients. Currently operating in stealth mode, the company is working on innovative solutions within the semiconductor industry to address safety-related challenges.
Proscia
Series C in 2024
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Cyware
Series C in 2023
Cyware specializes in providing cyber fusion solutions that enable organizations to detect and mitigate advanced cyberattacks effectively. Its technology allows businesses to establish a virtual cyber fusion center, integrating various tools such as an advanced threat intelligence platform, security automation, and security case management. These solutions enhance threat visibility and facilitate secure collaboration and information sharing among enterprises, information sharing and analysis organizations, managed security service providers, and government entities. By automating threat response and offering context-rich analysis, Cyware helps clients manage security threats in real-time, improving operational efficiency while minimizing costs and analyst fatigue.
Transcend Therapeutics
Series A in 2023
Transcend Therapeutics, Inc., established in 1992 in Waltham, Massachusetts, is a clinical-stage company focused on developing pharmaceuticals to address diseases associated with oxidative stress and tissue damage. The company aims to create psychoactive medicines targeting specific brain regions involved in neuropsychiatric disorders. By doing so, Transcend Therapeutics seeks to enable healthcare professionals to facilitate positive changes in brain function and behavior for patients suffering from these conditions.
ETCH
Venture Round in 2022
ETCH commercializes a chemical process that generates low-cost hydrogen by splitting natural gas into hydrogen and solid carbon. The process can be powered by either natural gas, hydrogen, or electricity. Carbon generated by the process is pure and can be stored in environmentally benign facilities.
Evolved By Nature
Series C in 2022
Evolved By Nature, Inc. is a biotech company based in Medford, Massachusetts, specializing in the development of Activated Silk technology, which utilizes silk protein derived from discarded silkworm cocoons. Founded in 2013 by biomedical engineer Rebecca Lacouture and chemist Gregory Altman, the company aims to create sustainable and effective alternatives to traditional chemicals used in various industries. Evolved By Nature manufactures products for textiles, personal care, and medical applications, focusing on enhancing performance while reducing reliance on harmful substances. Its innovative liquid silk technology delivers pure silk molecules, offering advanced anti-aging benefits in skincare without synthetic fillers or harsh preservatives. Since its inception, the company has secured numerous patents for its molecular combinations, underscoring its commitment to advancing health for both people and the planet.
CybSafe
Series B in 2022
CybSafe is a cybersecurity software company that offers a cloud-based platform designed to enhance cyber awareness and improve security behaviors among users. Through its mobile and web applications, CybSafe provides real-time, tailored assistance, educational resources, and personalized nudges to help individuals make better security decisions. The platform leverages a data-driven model of human behavior and utilizes SebDB, a comprehensive security behavior database, to deliver insights and metrics related to security behavior, culture, and risk. By employing scientifically proven interventions and personalized tactics, CybSafe aims to reduce risks and foster a more resilient workforce for organizations of all sizes.
Proscia
Series C in 2022
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Torigen Pharmaceuticals
Venture Round in 2022
Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.
WATT Fuel Cell
Venture Round in 2022
WATT Fuel Cell Corporation is a developer and manufacturer of solid oxide fuel cell (SOFC) systems and components, based in Mount Pleasant, Pennsylvania. Founded in 2010, the company specializes in creating fuel cells that operate on readily available hydrocarbon fuels, including natural gas, propane, JP-8, and diesel. WATT's technology is designed to provide efficient, clean, and environmentally responsible energy solutions for various sectors, including marine and recreational vehicles, emergency response, military, and remote power applications. The company offers a hybrid SOFC system that integrates hydrocarbon fuels with renewable energy sources like solar and wind, optimizing power output and energy storage. Its modular design allows for scalable solutions, enabling clients to increase power capacity by adding additional modules as needed, similar to a blade server configuration.
TrueFort
Series B in 2021
TrueFort Inc. is a cybersecurity company based in Weehawken, New Jersey, founded in 2015. It specializes in real-time application and cloud workload protection solutions, focusing on securing critical applications and infrastructure. The company's flagship platform, Fortress, offers a unique approach to security by leveraging advanced behavioral analysis, machine intelligence, and automation. This platform supports zero trust application environments and addresses various security challenges through a unified solution that enhances visibility and protection against cyber threats. TrueFort's technology enables clients to utilize agents already deployed in their systems, facilitating seamless integration while significantly reducing risks associated with excessive trust.
Babson Diagnostics
Series B in 2021
Babson Diagnostics, Inc. is a healthcare technology company based in Austin, Texas, focused on revolutionizing blood testing by enabling lab-quality diagnostics in retail settings such as pharmacies and grocery stores. Founded in 2017, the company has developed an innovative device that collects blood samples using only a small volume of capillary blood from the finger, significantly reducing the amount needed compared to traditional venipuncture methods. This approach not only simplifies the blood collection process but also ensures that results are accurate and can be delivered within a short wait time. By analyzing these samples at CLIA-certified clinical laboratories, Babson Diagnostics aims to make diagnostic testing more accessible and convenient for consumers.
Cyware
Series B in 2021
Cyware specializes in providing cyber fusion solutions that enable organizations to detect and mitigate advanced cyberattacks effectively. Its technology allows businesses to establish a virtual cyber fusion center, integrating various tools such as an advanced threat intelligence platform, security automation, and security case management. These solutions enhance threat visibility and facilitate secure collaboration and information sharing among enterprises, information sharing and analysis organizations, managed security service providers, and government entities. By automating threat response and offering context-rich analysis, Cyware helps clients manage security threats in real-time, improving operational efficiency while minimizing costs and analyst fatigue.
Sunflower Therapeutics
Venture Round in 2021
Sunflower Therapeutics is a biotechnology company focused on advancing protein manufacturing solutions to enhance global access to biological medicines. By employing strain engineering and integrated process development, the company aims to create efficient, automated systems for protein production. These innovations are designed to support a wide range of applications, including new medicines and food products, allowing clients to significantly reduce the time and costs associated with developing and manufacturing biologics. Sunflower Therapeutics emphasizes values such as wellness, integrity, ethics, equity, community, and efficiency in its operations, reflecting its commitment to benefiting the global population.
TBT Pharma
Seed Round in 2020
TBT Pharma is a dermatology startup established in 2019 and headquartered in Baltimore, Maryland. The company focuses on repurposing generic and off-patent compounds to develop therapies aimed at treating various skin conditions, particularly psoriasis and other inflammatory disorders. TBT Pharma has developed four main patented products that offer topical applications for problematic skin, enabling healthcare professionals to effectively address the needs of patients suffering from these debilitating conditions. Through its innovative approach, TBT Pharma aims to improve the quality of life for individuals affected by skin diseases.
Cyware
Series A in 2020
Cyware specializes in providing cyber fusion solutions that enable organizations to detect and mitigate advanced cyberattacks effectively. Its technology allows businesses to establish a virtual cyber fusion center, integrating various tools such as an advanced threat intelligence platform, security automation, and security case management. These solutions enhance threat visibility and facilitate secure collaboration and information sharing among enterprises, information sharing and analysis organizations, managed security service providers, and government entities. By automating threat response and offering context-rich analysis, Cyware helps clients manage security threats in real-time, improving operational efficiency while minimizing costs and analyst fatigue.
Baton
Series A in 2020
Baton Technologies, Inc. is a New York-based company that specializes in business software automation. Founded in 2018, it offers a software-as-a-service platform designed to streamline and manage the software implementation process for clients. Baton aims to enhance the post-sales implementation experience by providing tools that facilitate organization and communication, particularly through the use of email, spreadsheets, and regular updates. As an early-stage startup, Baton focuses on improving efficiency in the implementation phase, allowing customers to navigate the complexities of software deployment more effectively.
Lifesprout
Series A in 2020
LifeSprout is developing the next generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine. They offer revolutionary products for aesthetic and regenerative medicine. They have created a platform that looks and behaves like the body’s own tissues. The company is turning this into a suite of products for millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease.
Axis Security
Series A in 2020
Axis Security Inc. is a cybersecurity company founded in 2018 and based in Palo Alto, California. It specializes in providing Zero Trust Network Access solutions, focusing on secure remote access to applications. The company's platform employs application isolation technology and a context-aware security approach, evaluating various factors to ensure that only authorized users can access specific resources within a network. This allows organizations to maintain control over sensitive information while enabling access for employees, partners, and other stakeholders. Through its cloud security and analytics solutions, Axis Security aims to enhance data protection and streamline secure access to business applications.
READY Robotics
Series B in 2020
READY Robotics Corp., founded in 2016 and headquartered in Baltimore, Maryland, specializes in developing ForgeOS, an innovative industrial operating system designed for robotics and automation. This platform utilizes patented technology to enable manufacturers to deploy and manage robots and automation systems through a standardized suite of low-code applications. ForgeOS is particularly suited for high-mix, low-volume manufacturing environments, which have traditionally posed challenges for automation. The system allows operators to control and program a wide range of robotic devices and industrial automation equipment from major brands through a single interface, minimizing the need for extensive training. By connecting to hundreds of robot models and thousands of industrial devices, READY Robotics enhances productivity and streamlines operations in complex manufacturing settings.
Cyware
Seed Round in 2019
Cyware specializes in providing cyber fusion solutions that enable organizations to detect and mitigate advanced cyberattacks effectively. Its technology allows businesses to establish a virtual cyber fusion center, integrating various tools such as an advanced threat intelligence platform, security automation, and security case management. These solutions enhance threat visibility and facilitate secure collaboration and information sharing among enterprises, information sharing and analysis organizations, managed security service providers, and government entities. By automating threat response and offering context-rich analysis, Cyware helps clients manage security threats in real-time, improving operational efficiency while minimizing costs and analyst fatigue.
Capital Rx
Series A in 2019
Capital Rx, Inc. is a pharmacy benefit manager that specializes in managing self-insured prescription benefit plans for employers, unions, and government entities. Founded in 2017 and headquartered in New York, the company aims to transform the pricing and administration of prescriptions in the U.S. through its innovative Clearinghouse Model, which enhances transparency in the pharmacy supply chain and reduces costs for employer groups. By integrating various components of the pharmacy ecosystem into a single platform, Capital Rx improves administrative workflows, clinical oversight, and patient-provider coordination. This approach not only increases drug price visibility but also focuses on enhancing patient outcomes and healthcare efficiency, ultimately fostering better engagement between healthcare providers and patients.
TrueFort
Series A in 2019
TrueFort Inc. is a cybersecurity company based in Weehawken, New Jersey, founded in 2015. It specializes in real-time application and cloud workload protection solutions, focusing on securing critical applications and infrastructure. The company's flagship platform, Fortress, offers a unique approach to security by leveraging advanced behavioral analysis, machine intelligence, and automation. This platform supports zero trust application environments and addresses various security challenges through a unified solution that enhances visibility and protection against cyber threats. TrueFort's technology enables clients to utilize agents already deployed in their systems, facilitating seamless integration while significantly reducing risks associated with excessive trust.
Vixiar
Series A in 2019
Vixiar Medical, Inc., founded in 2013 and located in Annapolis, Maryland, specializes in the development of non-invasive and cost-effective devices for monitoring cardiopulmonary diseases. The company focuses on conditions that impose significant clinical and economic challenges. Its flagship product, Indicor, is a handheld point-of-care device coupled with a digital platform, designed specifically for monitoring worsening heart failure. Through its innovative approach, Vixiar Medical aims to improve patient outcomes and reduce healthcare costs associated with cardiopulmonary conditions.
Torigen Pharmaceuticals
Series A in 2019
Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.
Proscia
Series A in 2018
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
WATT Fuel Cell
Venture Round in 2018
WATT Fuel Cell Corporation is a developer and manufacturer of solid oxide fuel cell (SOFC) systems and components, based in Mount Pleasant, Pennsylvania. Founded in 2010, the company specializes in creating fuel cells that operate on readily available hydrocarbon fuels, including natural gas, propane, JP-8, and diesel. WATT's technology is designed to provide efficient, clean, and environmentally responsible energy solutions for various sectors, including marine and recreational vehicles, emergency response, military, and remote power applications. The company offers a hybrid SOFC system that integrates hydrocarbon fuels with renewable energy sources like solar and wind, optimizing power output and energy storage. Its modular design allows for scalable solutions, enabling clients to increase power capacity by adding additional modules as needed, similar to a blade server configuration.
SafeBreach
Series B in 2018
SafeBreach Inc. is a cybersecurity company that specializes in breach and attack simulation (BAS). Founded in 2014 and headquartered in Sunnyvale, California, with an additional location in Tel Aviv, Israel, SafeBreach offers a platform that enables organizations to proactively assess their security posture. The platform utilizes a comprehensive Hacker's Playbook, which includes real-world breach methods, to simulate potential attacks across various network segments, cloud environments, and endpoints. By mimicking the tactics of virtual hackers, SafeBreach helps businesses identify vulnerabilities and improve their security controls before actual breaches occur. The platform integrates seamlessly with security information and event management systems, ticketing systems, and automation vendors, allowing for enhanced incident response and remediation. Funded by notable investors, SafeBreach continues to innovate in the field of cybersecurity, providing vital insights to strengthen enterprise defenses against evolving threats.
AppliedEA
Venture Round in 2018
AppliedEA develops industrial software focused on monitoring and analyzing autonomous mobile machines in real-time. By utilizing big data and machine learning technologies, the company aims to enhance the reliability of these machines while reducing their failure rates and associated maintenance costs. Its application of Condition-Based Maintenance (CBM) methodology specifically targets mobile machines, including unmanned aerial vehicles, to improve performance benchmarks and minimize liability for aviation companies. Through these innovations, AppliedEA seeks to provide a more efficient and cost-effective solution for the maintenance and operation of both manned and autonomous mobile systems.
Sustained Nano Systems
Venture Round in 2017
Sustained Nano Systems is a biotechnology company specializing in advanced drug delivery technologies. The company has developed a flagship technology that enables short and long-term micro-dosing, allowing for targeted delivery to cells for various therapeutic applications. Their innovative approach leverages expertise in small particle behavior to enhance drug administration, particularly in chronic disease management where repetitive dosing is often necessary. By offering both injectable and implant formats, Sustained Nano Systems aims to improve the efficacy of existing and emerging drug therapies, ultimately benefiting healthcare providers and patients alike.
READY Robotics
Seed Round in 2016
READY Robotics Corp., founded in 2016 and headquartered in Baltimore, Maryland, specializes in developing ForgeOS, an innovative industrial operating system designed for robotics and automation. This platform utilizes patented technology to enable manufacturers to deploy and manage robots and automation systems through a standardized suite of low-code applications. ForgeOS is particularly suited for high-mix, low-volume manufacturing environments, which have traditionally posed challenges for automation. The system allows operators to control and program a wide range of robotic devices and industrial automation equipment from major brands through a single interface, minimizing the need for extensive training. By connecting to hundreds of robot models and thousands of industrial devices, READY Robotics enhances productivity and streamlines operations in complex manufacturing settings.
GreenSight
Seed Round in 2016
GreenSight Agronomics, Inc. is a company based in Brookline, Massachusetts, specializing in the manufacture of drones and a cloud-based platform for agricultural and turf management. Founded in 2015, GreenSight develops advanced drone systems equipped with sophisticated sensors and a data analytics platform. These technologies are designed to monitor plant health, detect pests, and manage irrigation and crop conditions, providing essential services for the golf course and agricultural industries. The company’s platform enables the automation of aerial intelligence, allowing for daily low-altitude data collection without labor costs. By integrating its technology into golf course management, GreenSight aims to significantly reduce water and chemical usage, potentially saving the industry over $1 billion annually. This comprehensive digital management solution helps land managers address issues such as drought and plant stress, improving operational efficiency and enhancing the quality of turf and crops.
Proscia
Seed Round in 2016
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.
Socure
Series A in 2015
Socure Inc. is a provider of digital identity verification solutions, focusing on real-time identity authentication through its Socure ID+ platform. This predictive analytics platform utilizes artificial intelligence and machine learning to authenticate identities by analyzing a multitude of online and offline data sources, including email, phone numbers, addresses, IP addresses, and social media profiles. Socure's offerings include Aida, an AI-driven bot for validating digital identities, Docv, an omnichannel document verification solution, and Sigma Synthetic Fraud, which tackles synthetic identity fraud. The company addresses the needs of various sectors, including software, consulting, and financial firms, through compliance initiatives such as customer identification programs, know your customer requirements, and anti-money laundering measures. Founded in 2012 and headquartered in New York, Socure has established partnerships with key industry players to enhance its service delivery.
DriverUp
Series A in 2015
DriverUp Corp. operates an online marketplace focused on automotive financing, enabling direct participation for investors in this market. Founded in 2012 and based in Austin, Texas, DriverUp enhances the financing experience for both car dealers and buyers through its application portal, which streamlines the search for financing terms and allows users to secure purchases online. The platform employs proprietary technology and advanced data analytics to facilitate efficient processing of auto loans, providing transparency and detailed reporting. It uniquely allows accredited investors, including hedge funds and high-net-worth individuals, to engage directly in high-yield auto lending opportunities. Previously known as Sierra Holdings LLC, the company rebranded to DriverUp Corp. in February 2015.
Intellihot
Venture Round in 2015
Intellihot specializes in the manufacture of tankless water heating systems tailored for both residential and commercial use. Founded in 2005, the company emerged from a practical need when a traditional water heater malfunctioned, leading to significant water damage. Intellihot's systems are designed to conserve space by eliminating the need for bulky storage tanks, and they incorporate advanced technology, including Wi-Fi and 3G/4G connectivity. This connectivity allows users to monitor and analyze water usage patterns, providing an efficient on-demand heating solution that optimizes performance and resource use. The innovative design of Intellihot's products has garnered recognition and includes several patents pending.
Una Software
Una Software is a developer of a revenue performance management system aimed at enhancing the customer journey. The platform provides a comprehensive suite of features, including reporting and analytics, integrated planning, intelligent forecasting and modeling, and a unified view of the entire customer experience. Additionally, it synchronizes growth strategies and offers AI-driven alerts and insights, facilitating effective revenue orchestration and supporting businesses in implementing informed decisions.
Uviquity
Uviquity is a semiconductor manufacturer based in Raleigh, North Carolina, focused on enhancing safety for its clients. Currently operating in stealth mode, the company is working on innovative solutions within the semiconductor industry to address safety-related challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.